Cost Effectiveness of Insulin Glargine plus Oral Antidiabetes Drugs Compared with Premixed Insulin Alone in Patients with Type 2 Diabetes Mellitus in Canada

Author： Tunis Sandra L.  

Publisher： Adis International

ISSN： 1175-5652

Source： Applied Health Economics and Health Policy, Vol.8, Iss.4, 2010-07, pp. : 267-280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Comparison of Costs among Patients with Type 2 Diabetes Mellitus Who Initiated Therapy with Exenatide or Insulin Glargine

By Misurski Derek  

Applied Health Economics and Health Policy, Vol. 7, Iss. 4, 2009-12 ,pp. : 245-254

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Self-Monitoring of Blood Glucose (SMBG) for Patients with Type 2 Diabetes and Not on Insulin: Impact of Modelling Assumptions on Recent Canadian Findings

By Tunis Sandra L.  

Applied Health Economics and Health Policy, Vol. 9, Iss. 6, 2011-11 ,pp. : 351-365

Adis International

Access to resources Recommend Favorite

Insulin Therapy in Patients with Type 2 Diabetes Mellitus: Shared Care Versus Secondary Outpatient Care in The Netherlands

By Hutubessy R.C.W.  

Disease Management & Health Outcomes, Vol. 9, Iss. 6, 2001-01 ,pp. : 337-344

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Preventive Screening Programmes for Type 2 Diabetes Mellitus in Germany

By Schaufler Thilo M.   Wolff Malte  

Applied Health Economics and Health Policy, Vol. 8, Iss. 3, 2010-05 ,pp. : 191-202

Adis International

Access to resources Recommend Favorite

Use of Short-Acting Insulin Secretagogues for Type 2 Diabetes Mellitus: Considerations for National Health Systems

By Salas Maribel  

Disease Management & Health Outcomes, Vol. 13, Iss. 4, 2005-01 ,pp. : 219-224

Adis International

Access to resources Recommend Favorite